Body

JSCM publishes revised International Standards for Neurological Classification of Spinal Cord Injury

West Orange, NJ. December 28, 2011. The 2011 revision of the International Standards for the Neurological Classification of Spinal Cord Injury (ISNCSCI) was published in the November 2011 issue of the Journal of Spinal Cord Medicine. The accompanying reference article by Steven Kirshblum et al clarifies the modifications to this newest revision. Both are available for free download via http://www.ingentaconnect.com/content/maney/scm (#6, Nov 2011).

Don't put all your eggs in 1 basket -- or all your horses on 1 pasture

Winters in the Gobi desert are usually long and very cold but the winter of 2009-2010 was particularly severe. Millions of livestock died in Mongolia and the re-introduced wild Przewalski's horse population crashed dramatically. Petra Kaczensky and Chris Walzer from the University of Veterinary Medicine, Vienna have used spatially explicit loss statistics, ranger survey data and GPS telemetry to provide insights into the effect of a catastrophic climate event on wild horses, wild asses and livestock.

Gene identified in increasing pancreatic cancer risk

PHILADELPHIA — Mutations in the ATM gene may increase the hereditary risk for pancreatic cancer, according to data published in Cancer Discovery, the newest journal of the American Association for Cancer Research.

Pancreatic cancer is one of the most morbid cancers, with less than 5 percent of those diagnosed with the disease surviving to five years. Approximately 10 percent of patients come from families with multiple cases of pancreatic cancer.

Ovarian cancer study proves drug delays disease progression, may improve survival

(TORONTO, Canada – Dec. 29, 2011) – Treating ovarian cancer with the drug bevacizumab ("Avastin") delays the disease and may also improve survival, show the results of an international clinical trial co-led by Drs. Amit Oza of the Princess Margaret Cancer Program, University Health Network and Timothy Perren, St James's Institute of Oncology, Leeds, UK.

Targeted therapy extends progression-free survival of patients with advanced ovarian cancer

PHILADELPHIA, PA (December 28, 2011)—Targeted drugs, which block or disrupt particular molecules involved in the growth of tumors, have been shown to be effective treatments against many types of cancer. A new phase 3 clinical trial conducted by the Gynecologic Oncology Group (GOG) showed that a targeted therapy called bevacizumab (Avastin) effectively delayed the progression of advanced ovarian cancer. Patients with newly diagnosed advanced ovarian cancer now typically undergo surgery and chemotherapy, but the new research suggests an additional avenue of treatment.

Netherlands mass gathering study finds substance abuse a small but significant problem

In a study of 3.8 million attendees to 249 raves over 12 years, researchers found that almost 27,897 people visited a first aid station, and more than a third (10,100) reported a substance-related problem. Of these, 515 required professional medical care, and 16 cases were life-threatening. Most (66.7%) substance-related problems were associated with ecstasy, alcohol, or both. People using GHB most often required professional medical care, although the authors found no evidence for life-threatening, acute effects of the drug.

Microbial communities on skin affect humans' attractiveness to mosquitoes

The microbes on your skin determine how attractive you are to mosquitoes, which may have important implications for malaria transmission and prevention, according to a study published Dec. 28 in the online journal PLoS ONE.

FDA urges parents to read infant acetaminophen labels carefully

IRVINGTON, NY, DECEMBER 28, 2011 – Acetaminophen is one of the most commonly used pain and fever relievers for infants and children and is safe and effective when used as directed. However, with recent dosing changes to liquid acetaminophen products for infants, the FDA last week issued a press release urging parents to know the concentration and read the label as the new, less concentrated form of the popular pain reliever arrives on store shelves.

UT Southwestern research suggests new way to ensure effectiveness of TB treatment

DALLAS – Dec. 22, 2011 – A UT Southwestern Medical Center study using a sophisticated "glass mouse" research model has found that multidrug-resistant tuberculosis (TB) is more likely caused in patients by speedy drug metabolism rather than inconsistent doses, as is widely believed.

Collaborative effort uncovers DNA duplications that may be responsible for genomic-based diseases

An important part of saving a species is often understanding its DNA. Through a collaborative effort including 14 scientists representing organizations across Europe and the United States, researchers have been able to analyze the genome of the great ape species of the world.

Scientists fixate on Ric-8 to understand trafficking of popular drug receptor targets

Half the drugs used today target a single class of proteins – and now scientists have identified an important molecular player critical to the proper workings of those proteins critical to our health.

A protein known as Ric-8 plays a vital role, according to new results from a team led by Gregory Tall, Ph.D., assistant professor of Pharmacology and Physiology at the University of Rochester Medical Center. The work was published recently in Science Signaling.

More information on trial site investigators needed

Despite the importance of site investigators to the success of multicentre clinical trials, inadequate public information is available about their recruitment performance. In this week's PLoS Medicine, Rafael Dal-Ré and colleagues argue that that sponsors should disclose the recruitment targets of all site investigators on ClinicalTrials.gov before a trial starts, as well as their final recruitment. Information on issues that could have affected recruitment should also be provided.

Analysis does not support genetic test before use of anti-clotting drug

CHICAGO – Although the U.S. Food and Drug Administration (FDA) has recommended that a certain type of genetic testing (for the genotype CYP2C19) be considered before prescribing the drug clopidogrel to identify individuals who may be less responsive to the medication, a review and analysis of previous studies did not find an overall significant association between the CYP2C19 genotype and cardiovascular events, according to a study in the December 28 issue of JAMA.

Oxidative DNA damage repair

Oxidative stress is the cause of many serious diseases such as cancer, Alzheimer's, arteriosclerosis and diabetes. It occurs when the body is exposed to excessive amounts of electrically charged, aggressive oxygen compounds. These are normally produced during breathing and other metabolic processes, but also in the case of ongoing stress, exposure to UV light or X-rays. If the oxidative stress is too high, it overwhelms the body's natural defences.

Frogs use calls to find mates with matching chromosomes, University of Missouri researchers find

Columbia, MO – When it comes to love songs, female tree frogs are pretty picky. According to a new study from the University of Missouri, certain female tree frogs may be remarkably attuned to the songs of mates who share the same number of chromosomes as they do. The discovery offers insight into how new frog species may have evolved.